Biotricity, Inc. (BTCY)
 OTCMKTS  · Delayed Price · Currency is USD  
0.5371
 -0.0328 (-5.76%)
  Nov 3, 2025, 3:58 PM EST
Biotricity Revenue
Biotricity had revenue of $3.87M in the quarter ending June 30, 2025, with 21.00% growth. This brings the company's revenue in the last twelve months to $14.46M, up 18.12% year-over-year. In the fiscal year ending March 31, 2025, Biotricity had annual revenue of $13.79M with 14.32% growth.
Revenue (ttm) 
 14.46M
Revenue Growth 
 +18.12%
P/S Ratio 
 1.00
Revenue / Employee 
 314.40K
Employees 
 46
Market Cap 
14.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Mar 31, 2025 | 13.79M | 1.73M | 14.32% | 
| Mar 31, 2024 | 12.06M | 2.42M | 25.15% | 
| Mar 31, 2023 | 9.64M | 1.99M | 26.00% | 
| Mar 31, 2022 | 7.65M | 4.27M | 126.02% | 
| Mar 31, 2021 | 3.38M | 1.97M | 138.75% | 
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| American Oncology Network | 1.76B | 
| Veradigm | 588.02M | 
| Jushi Holdings | 256.36M | 
| Glass House Brands | 221.55M | 
| Elite Pharmaceuticals | 105.45M | 
| Silence Therapeutics | 27.17M | 
| China New Energy Group Co. | 12.51M | 
| Northwest Biotherapeutics | 1.09M | 
Biotricity News
- 7 weeks ago - Biotricity (BTCY) Expands Market Reach Through New Partnership - GuruFocus
 - 7 weeks ago - Health-E Commerce® and Biotricity® Collaborate to Expand Remote Cardiac Monitoring with Bioheart® for Flexible Spending Account (FSA) and Health Savings Account (HSA) Users - PRNewsWire
 - 2 months ago - Biotricity and B-Secur Target the Consumer Wearables Market with Expansion of Next-Gen Cardiac Monitoring Platform - GlobeNewsWire
 - 2 months ago - Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved Margins - GlobeNewsWire
 - 2 months ago - Biotricity to Host Fiscal 2026 First Quarter Financial Results and Business Update Call on August 14th - GlobeNewsWire
 - 3 months ago - BTCY: CA: A Fun Idea With Yield But Risky - Seeking Alpha
 - 3 months ago - Biotricity, Inc. (BTCY) Q4 2025 Earnings Conference Call Transcript - Seeking Alpha
 - 3 months ago - Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach - GlobeNewsWire